Skip to content
WeighLab

Mojoon vs Kin Meds

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Mojoon

Provider comparison

Shoppers comfortable reading past a marketing headline to a lower published starting-dose price.

Semaglutide / month
$350/mo0.25 mg dose, compounded
Tirzepatide / month
$390/moStarting dose; rises to $490, compounded
Index 65/100 · Grade CChecked October 2026

Kin Meds

Provider comparison

Readers comparing compounded entry prices with branded prescribing who will confirm their dose-specific bill and state eligibility.

Semaglutide / month
$199/moStarting (30-day compounded injection; dose-specific quote to confirm)
Tirzepatide / month
$249/moStarting (30-day compounded injection with B12; dose-specific quote to confirm)
Index 65/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 65/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Mojoon
48 states; excludes New Mexico and Mississippi
Kin Meds
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Mojoon

Kin Meds

Semaglutide / month
Mojoon: $350/mo0.25 mg dose, compounded
Kin Meds: $199/moStarting (30-day compounded injection; dose-specific quote to confirm)
Tirzepatide / month
Mojoon: $390/moStarting dose; rises to $490, compounded
Kin Meds: $249/moStarting (30-day compounded injection with B12; dose-specific quote to confirm)
Semaglutide / year (modeled)
Mojoon: $4,200
Kin Meds: $2,388
Tirzepatide / year (modeled)
Mojoon: $4,680
Kin Meds: $2,988
State availability
Mojoon: 48 states; excludes New Mexico and Mississippi
Kin Meds: Coverage not published
Oral / sublingual option listed
Mojoon: Yes
Kin Meds: Yes
Brand-name access listed
Mojoon: Not confirmed
Kin Meds: Yes
Provider facts checked
Mojoon: October 2026
Kin Meds: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Mojoon

Shoppers comfortable reading past a marketing headline to a lower published starting-dose price.

Reasons to consider it

  • Publishes an actual price range ($350-$520/treatment) rather than a single vague 'starting at' figure, and explains why the price rises (monthly dose escalation from 0.25 mg to 2.4 mg)
  • Claims LegitScript certification, and pharmacy licensure across all 50 states for dispensing even though provider coverage is 48 states
  • No long-term contract or hidden fees claimed on the product page

What to weigh up

  • Semaglutide rises from $350 to $520 per monthly course as the dose increases; budget beyond the starting rate
  • Tirzepatide is $390 to $490 per monthly course; get the amount at your prescribed dose confirmed
  • No LegitScript certificate number, no named medical director, and no named compounding pharmacy anywhere on the site — only generic 'licensed medical team' language

Kin Meds

Readers comparing compounded entry prices with branded prescribing who will confirm their dose-specific bill and state eligibility.

Reasons to consider it

  • Current medication pages publish compounded starting prices
  • Names Rush Pharmacy and Strive Pharmacy as dispensing partners
  • Lists branded Wegovy, Zepbound and Foundayo with the separate consultation fee disclosed

What to weigh up

  • Compounded rates are starting prices; a complete dose-specific ladder is not published
  • Brand-name plans start at $149 monthly for consultation alone, with medication billed separately
  • No treatment-specific state list or individual medical director is published

Regulatory note: the FDA issued a warning letter to Kin Meds in February 2026. We still list and link to Kin Meds; you should know the letter is on the public record before you decide.

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MojoonKin Meds
Normalized Cost/Month
Mojoon:
37/100
Kin Meds:
64/100
Price Transparency
Mojoon:
78/100
Kin Meds:
92/100
Nationwide Access
Mojoon:
78/100
Kin Meds:
24/100
Formulation Options
Mojoon:
77/100
Kin Meds:
95/100
Clinical Oversight
Mojoon:
74/100
Kin Meds:
62/100
Contract Flexibility
Mojoon:
55/100
Kin Meds:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.